Navigation Links
Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Date:1/5/2012

GREENWOOD VILLAGE, Colo., Jan. 5, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE - News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it will hold a Web Cast on Thursday, January 26, 2012 at 4:15 EST. The purpose of the call will be to update our shareholders on the company's progress and a press release on January 16th will announce how the shareholders and the general public can join and listen to the call. 

The company will present a 30-minute overview of the company's progress and future plans and then open the call to a Q & A session.  The subjects covered will include:

  • Ampio's sexual dysfunction drug portfolio Zertane™, for the treatment of premature ejaculation (PE) and a combination drug that combines Zertane™ and a PDE5 inhibitor for simultaneous treatment of PE and erectile dysfunction (ED)
  • Ampio's anti-inflammatory drug Ampion™, and an update on the Australian clinical trial for the treatment of Osteoarthritis in the knee
  • Ampio's vascular permeability drug Optina™, and an update on the Canadian Phase II clinical trial for the treatment of patients with Diabetic Macular Edema (DME), which is a common complication of Diabetes Mellitus

"Our progress in 2011 and our clinical plans going forward are difficult to explain in periodic press releases." said Michael Macaluso, Ampio's Chairman. "This format will allow a more nuanced presentation of the direction that Ampio has taken, as well as the short term future plans for each of our products."

Homework for shareholders

For those shareholders who would like to prepare for this webcast by reviewing a few of Dr. Bar-Or's peer-reviewed articles reportin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
2. Ampio Responds to Recent Publications by Anonymous Short Sellers
3. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
4. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
5. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
6. Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
7. Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases
8. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
9. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
10. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
11. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition ... Guidebook Series (4) 2013 Edition Material and Clinical ... Drug Registration: A Guidebook of Registration Application for ... to its online database. The traditional ... are always regarded by occidental as mysterious medicines. ...
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
(Date:5/21/2013)... 2013 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China and the parent of Chang,an Hospital, ... first quarter ended March 31, 2013 [1] . ... revenue, which consists of net revenues generated from the ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
... 28, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... Conference being held May 2 to 4, 2011 at the ... Merrill Lynch Healthcare Conference being held May 10 to 12, ... Price, Pharmasset,s President and Chief Executive Officer, will provide an ...
... 28, 2011 The U.S. Food and Drug ... with prednisone (a steroid) to treat patients with ... prior docetaxel (chemotherapy). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... sex hormone testosterone stimulates prostate tumors to grow. ...
Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3
(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
(Date:5/22/2013)... 2013 In the past decade, ... and courts with donated uniforms, shoes, balls and ... dedicated to partnering with manufacturers to provide youth with ... of $8.8 million in sports and fitness equipment over ... kids outfitted for physical activity. , An inaugural ...
(Date:5/22/2013)... Following the success of last year’s 1,000 ... Body Boot Camp Kincardine has announced it will be ... on June 3rd at its Kincardine fitness center ... Ontario.     , Fit Body Boot Camp’s 1,000 lb. Meltdown ... residents to lose a total of 1,000 pounds in ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...
(Date:5/22/2013)... 2013 Poor adherence to appropriate medication ... medical complications and death (some 125,000 deaths in the ... increased health-care costs. It’s been estimated that between 33% ... to poor medication adherence — a reality that costs ... Indeed, so dire is the degree of medication non-adherence ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
... PHILADELPHIA, Nov. 13 Lippincott Williams & Wilkins (LWW) ... Nurses Association (HPNA) has appointed Betty Ferrell, PhD, MA, ... of Hospice & Palliative Nursing. LWW is part of ... business intelligence for students, professionals, and institutions in medicine, ...
... to Create 1,500 Jobs , HERSHEY, Pa., Nov. 13 ... on the new Penn State Hershey Children,s Hospital and said ... economy, but most importantly, for sick children and their families. ... and another 1,200 jobs once the facility is completed. , ...
... to absorb potent antioxidant , FRIDAY, Nov. 13 (HealthDay ... of the yellow curry ingredient curcumin, which is being ... cancer, psoriasis and Alzheimer,s disease. , Curcumin, the active ... However, digestive juices in the gastrointestinal tract quickly destroy ...
... Md., Nov. 13 Several weeks ago, the FDA announced ... the post-harvest processing of raw Gulf Coast oysters harvested in ... policy, which would affect about 25% of the total annual ... who suffer severe and painful illness and death from the ...
... Calif., Nov. 13 Human Pheromone Sciences, Inc. (OTC Bulletin ... the three and nine month periods ended September 30, 2009. ... of $273,000 represented a 4% increase from the revenues of ... income of $10,000 ($0.00 per share) as compared with a ...
... ROCHESTER, Minn., Nov. 13 Here are highlights from the ... may cite this publication as often as you wish. Reprinting ... Letter attribution is required. Include the ... www.HealthLetter.MayoClinic.com ...
Cached Medicine News:Health News:Journal of Hospice & Palliative Nursing Names New Editor 2Health News:Journal of Hospice & Palliative Nursing Names New Editor 3Health News:Governor Rendell Helps to Break Ground for New Children's Hospital at Penn State Hershey 2Health News:FDA Statement on Vibrio Vulnificus in Raw Oysters 2Health News:FDA Statement on Vibrio Vulnificus in Raw Oysters 3Health News:Human Pheromone Sciences Announces Third Quarter Results 2Health News:Human Pheromone Sciences Announces Third Quarter Results 3Health News:Human Pheromone Sciences Announces Third Quarter Results 4Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 2Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 3Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 4Health News:November 2009 Mayo Clinic Health Letter Highlights Self-Care Tips for Hemorrhoids, Interactive Video Games Improve Health and Heart Failure Treatments 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: